Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.2616
-0.0184 (-6.57%)
At close: Jun 2, 2026, 4:00 PM EDT
0.2621
+0.0005 (0.19%)
Pre-market: Jun 3, 2026, 6:19 AM EDT

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $961.00K in the quarter ending March 31, 2026, a decrease of -27.18%. This brings the company's revenue in the last twelve months to $4.71M, down -24.36% year-over-year. In the year 2025, Ensysce Biosciences had annual revenue of $5.07M, down -2.75%.

Revenue (ttm)
$4.71M
Revenue Growth
-24.36%
P/S Ratio
0.52
Revenue / Employee
$470,788
Employees
10
Market Cap
2.43M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.07M-143.38K-2.75%
Dec 31, 20245.21M2.98M133.58%
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition